For the Inventor, By the Inventor

Enter inventor name

Seoul, South Korea

Woo Jin Park

USPTO Granted Patents = 12 (Patent Applications = 3)

EPO Patents = 6 (Patent Applications = 5)

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 14(Granted Patents)

Location History:

Seoul, KR (1996 - 2022)
Gwangju, KR (2016 - 2023)

Company Filing History:

Bethphagen Inc.

Gwangju Institute of Science and Technology

Daewoo Electronics Co., Ltd.

5. 1 out of 1,557

Seoul National University

Olives Biotherapeutics Inc.

Years Active: 1996-2025

Loading Chart...

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12377130 - Pharmaceutical composition comprising CCN5 as active ingredient, for preventing or treating retinal diseases (2025-08-05),

2. 12215362 - Pharmaceutical composition for prevention or treatment of heart failure (2025-02-04),

3. 11761019 - Pharmaceutical composition for preventing or treating cardiac arrhythmia (2023-09-19),

4. 11426441 - Composition comprising protein phosphatase 1 inhibitory peptide for treating vascular diseases (2022-08-30),

5. RE48636 - Decoy peptides inhibiting protein phosphatase 1-mediated dephosphorylation of phospholamban (2021-07-12),

6. 10682075 - Dry eye syndrome alert system through posture and work detection (2020-06-16),

7. 10479816 - Decoy peptides inhibiting protein phosphatase 1-medicated dephosphorylation of phospholamban (2019-11-19),

8. 10208085 - Decoy peptides inhibiting protein phosphatase 1-mediated dephosphorylation of phospholamban (2019-02-19),

9. 9855315 - Pharmaceutical composition comprising CCN5 for reducing cardiac fibrosis in a subject in need thereof (2018-01-02),

10. 9498519 - Amyloid-beta clearance (2016-11-22),

11. 8083647 - Treadmill system and operating method of the same (2011-12-27),

12. 5517478 - Disc player for performing disc loading and ejecting in response to (1996-05-14),

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…